These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 39039137)
1. Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul. Piccoli BC; Y Castro TR; Tessele LF; Casarin BC; Seerig AP; Vieira AA; Santos VT; Schwarzbold AV; Trindade PA Sci Rep; 2024 Jul; 14(1):16831. PubMed ID: 39039137 [TBL] [Abstract][Full Text] [Related]
2. Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil. Wink PL; Ramalho R; Monteiro FL; Volpato FCZ; Willig JB; Lovison OVA; Zavascki AP; Barth AL; Martins AF Microbiol Spectr; 2022 Feb; 10(1):e0151121. PubMed ID: 35171035 [TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023. Arantes I; Gomes M; Ito K; Sarafim S; Gräf T; Miyajima F; Khouri R; de Carvalho FC; de Almeida WAF; Siqueira MM; Resende PC; Naveca FG; Bello G; Microbiol Spectr; 2024 Mar; 12(3):e0383123. PubMed ID: 38315011 [TBL] [Abstract][Full Text] [Related]
4. Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA. Ramaiah A; Khubbar M; Akinyemi K; Bauer A; Carranza F; Weiner J; Bhattacharyya S; Payne D; Balakrishnan N Viruses; 2023 Sep; 15(9):. PubMed ID: 37766346 [TBL] [Abstract][Full Text] [Related]
5. Genomic surveillance of SARS-CoV-2 and emergence of XBB.1.16 variant in Rajasthan. Sharma P; Gautam S; Sharma A; Parsoya D; Deeba F; Pal N; Singh R; Sharma H; Bhomia N; Sharma RP; Potdar V; Malhotra B Indian J Med Microbiol; 2024; 50():100659. PubMed ID: 38945273 [TBL] [Abstract][Full Text] [Related]
6. Evolutionary and Phylogenetic Dynamics of SARS-CoV-2 Variants: A Genetic Comparative Study of Taiyuan and Wuhan Cities of China. Hussain B; Wu C Viruses; 2024 Jun; 16(6):. PubMed ID: 38932199 [TBL] [Abstract][Full Text] [Related]
7. Influenza outbreak during the surge of SARS-CoV-2 omicron in a metropolitan area from southern Brazil: genomic surveillance. de Abreu Góes Pereira VM; Gularte JS; Demoliner M; da Silva MS; Girardi V; Filippi M; Frohlich J; Fink P; Hansen AW; Ferreira HL; Afrough B; Kritz-Wilson A; Spilki FR J Med Virol; 2024 Oct; 96(10):e29944. PubMed ID: 39360646 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global Impact. Sil D; Gautam S; Saxena S; Joshi S; Kumar D; Mehta A; Jindal P; Sharma S; Pandey P; Diksha ; Singh A Curr Drug Targets; 2024; 25(8):517-525. PubMed ID: 38726782 [TBL] [Abstract][Full Text] [Related]
9. Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022-August 2023. Puenpa J; Chansaenroj J; Suwannakarn K; Poovorawan Y Sci Rep; 2024 Jan; 14(1):645. PubMed ID: 38182705 [TBL] [Abstract][Full Text] [Related]
10. Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil. Lamarca AP; de Almeida LGP; Francisco RDS; Lima LFA; Scortecci KC; Perez VP; Brustolini OJ; Sousa ESS; Secco DA; Santos AMG; Albuquerque GR; Mariano APM; Maciel BM; Gerber AL; Guimarães APC; Nascimento PR; Neto FPF; Gadelha SR; Porto LC; Campana EH; Jeronimo SMB; Vasconcelos ATR PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009835. PubMed ID: 34644287 [TBL] [Abstract][Full Text] [Related]
11. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil. Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G; Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1. Varela APM; Prichula J; Mayer FQ; Salvato RS; Sant'Anna FH; Gregianini TS; Martins LG; Seixas A; Veiga ABGD Infect Genet Evol; 2021 Dec; 96():105144. PubMed ID: 34798321 [TBL] [Abstract][Full Text] [Related]
13. Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023. Ma KC; Shirk P; Lambrou AS; Hassell N; Zheng XY; Payne AB; Ali AR; Batra D; Caravas J; Chau R; Cook PW; Howard D; Kovacs NA; Lacek KA; Lee JS; MacCannell DR; Malapati L; Mathew S; Mittal N; Nagilla RR; Parikh R; Paul P; Rambo-Martin BL; Shepard SS; Sheth M; Wentworth DE; Winn A; Hall AJ; Silk BJ; Thornburg N; Kondor R; Scobie HM; Paden CR MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(24):651-656. PubMed ID: 37319011 [TBL] [Abstract][Full Text] [Related]
14. Genetic diversity and genomic epidemiology of SARS-CoV-2 during the first 3 years of the pandemic in Morocco: comprehensive sequence analysis, including the unique lineage B.1.528 in Morocco. Djorwé S; Malki A; Nzoyikorera N; Nyandwi J; Zebsoubo SP; Bellamine K; Bousfiha A Access Microbiol; 2024; 6(10):. PubMed ID: 39376591 [TBL] [Abstract][Full Text] [Related]
15. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study. Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786 [TBL] [Abstract][Full Text] [Related]
16. Neutralization of SARS-CoV-2 Omicron XBB.1.5 and JN.1 variants after COVID-19 booster-vaccination and infection. Springer DN; Camp JV; Aberle SW; Deutsch J; Lammel O; Weseslindtner L; Stiasny K; Aberle JH J Med Virol; 2024 Jul; 96(7):e29801. PubMed ID: 38988204 [TBL] [Abstract][Full Text] [Related]
17. Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023. Link-Gelles R; Ciesla AA; Roper LE; Scobie HM; Ali AR; Miller JD; Wiegand RE; Accorsi EK; Verani JR; Shang N; Derado G; Britton A; Smith ZR; Fleming-Dutra KE MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(5):119-124. PubMed ID: 36730051 [TBL] [Abstract][Full Text] [Related]
18. Omicron variants of SARS-CoV-2: Epidemiological and clinical insights from a tertiary care center in Saudi Arabia. Dubaie B; Aldayel A; Alwethinani S; Alhuthil R; Alhamlan F; Alghamdi S; Alsuhaibani M; Aljumaah S; AlYabes O; AlBanyan E; Al-Hajjar S J Infect Public Health; 2024 Jun; 17(6):961-966. PubMed ID: 38608457 [TBL] [Abstract][Full Text] [Related]
19. Increased vaccine sensitivity of an emerging SARS-CoV-2 variant. Lewnard JA; Hong V; Kim JS; Shaw SF; Lewin B; Takhar H; Lipsitch M; Tartof SY Nat Commun; 2023 Jun; 14(1):3854. PubMed ID: 37386005 [TBL] [Abstract][Full Text] [Related]
20. Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion. Li P; Liu Y; Faraone JN; Hsu CC; Chamblee M; Zheng Y-M; Carlin C; Bednash JS; Horowitz JC; Mallampalli RK; Saif LJ; Oltz EM; Jones D; Li J; Gumina RJ; Liu S-L mBio; 2024 May; 15(5):e0075124. PubMed ID: 38591890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]